Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain-baré syndrome. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Market Cap | 236.009 Million | Shares Outstanding | 38.564 Million | Avg 30-day Volume | 199.881 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.5 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -142.476 Million |
Price to Book Value | 0.8656 | Operating Margin | 0.0 | Enterprise Value | -32.131 Million |
Current Ratio | 8.955 | EPS Growth | -1.072 | Quick Ratio | 8.768 |
1 Yr BETA | 1.3051 | 52-week High/Low | 23.61 / 2.06 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -43.9652 | Altman Z-Score | -1.9888 | Free Cash Flow to Firm | -99.846 Million |
Earnings Report | 2022-11-08 |
Please sign in first
3.1 Million total shares from 2 transactions
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
LEW JENNIFER EVP & CHIEF FINANCIAL OFFICER |
|
98,875 | 2022-07-11 | 3 |
LOVE DOUGLAS PRESIDENT & CEO |
|
300,000 | 2022-07-11 | 7 |
OVERDORF MICHAEL EVP & CHIEF BUSINESS OFFICER |
|
96,875 | 2022-07-11 | 2 |
MATTHEAKIS LARRY EVP & CHIEF SCIENTIFIC OFFICER |
|
54,688 | 2022-07-11 | 5 |
|
5,022,463 | 2022-07-07 | 2 | |
|
24,000 | 2022-06-09 | 1 | |
|
24,000 | 2022-06-09 | 1 | |
|
24,000 | 2022-06-09 | 1 | |
|
24,000 | 2022-06-09 | 1 | |
|
24,000 | 2022-06-09 | 3 | |
KESWANI SANJAY EVP & CHIEF MEDICAL OFFICER |
|
112,500 | 2022-02-11 | 1 |
YEDNOCK TED EVP & CHIEF SCIENTIFIC OFFICER |
|
78,554 | 2021-09-13 | 1 |
|
10,000 | 2021-06-02 | 0 | |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) |
|
No longer subject to file | 2020-07-28 | 0 |
BLACKSTONE HOLDINGS I/II GP L.L.C. |
|
No longer subject to file | 2020-07-28 | 0 |
|
No longer subject to file | 2020-07-28 | 0 | |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC BAIN CAPITAL LIFE SCIENCES FUND, L.P. BCIP LIFE SCIENCES ASSOCIATES, LP |
|
No longer subject to file | 2020-07-28 | 0 |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 | |
|
0 | 2020-07-23 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-07-13 18:48:09 -0400 | 2022-07-11 | A | 9,375 | a | 23,875 | direct | 7.7951 | 14.6993 | 16.7038 | 5 | 0.0 | 1 | ||||
2022-07-13 18:48:09 -0400 | 2022-07-11 | A | 75,000 | a | 75,000 | direct | ||||||||||
2022-07-13 18:58:01 -0400 | 2022-07-11 | A | 300,000 | a | 300,000 | direct | ||||||||||
2022-07-13 19:05:52 -0400 | 2022-07-11 | A | 300,000 | a | 300,000 | direct | ||||||||||
2022-07-13 19:37:48 -0400 | 2022-07-11 | A | 4,688 | a | 17,188 | direct | 7.7951 | 14.6993 | 16.7038 | 5 | 0.0 | 1 | ||||
2022-07-13 19:37:48 -0400 | 2022-07-11 | A | 37,500 | a | 37,500 | direct | ||||||||||
2022-07-13 19:40:44 -0400 | 2022-07-11 | A | 4,688 | a | 17,188 | direct | 7.7951 | 14.6993 | 16.7038 | 5 | 0.0 | 1 | ||||
2022-07-13 19:40:44 -0400 | 2022-07-11 | A | 37,500 | a | 37,500 | direct | ||||||||||
2022-07-13 19:49:56 -0400 | 2022-07-11 | A | 9,375 | a | 21,875 | direct | 7.7951 | 14.6993 | 16.7038 | 5 | 0.0 | 1 | ||||
2022-07-13 19:49:56 -0400 | 2022-07-11 | A | 75,000 | a | 75,000 | direct | ||||||||||
2022-07-13 19:46:31 -0400 | 2022-07-11 | A | 300,000 | a | 300,000 | direct | ||||||||||
SATTER MUNEER A - Director see footnote |
2022-07-11 20:42:34 -0400 | 2022-07-07 | P | 2,453,988 | $3.84 | a | 4,408,966 | indirect | 7.7465 | 20.6573 | 20.6573 | 6 | 0.0 | 1 | ||
SATTER MUNEER A - Director see footnote |
2022-07-11 20:42:34 -0400 | 2022-07-07 | P | 613,497 | $0.13 | a | 613,497 | indirect |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
ANNEXON INC ANNX | 2022-08-16 22:15:05 UTC | -0.0746 | 2.3946 | 450000 |
ANNEXON INC ANNX | 2022-08-16 21:45:03 UTC | -0.0158 | 2.3358 | 450000 |
ANNEXON INC ANNX | 2022-08-16 21:15:03 UTC | -0.0158 | 2.3358 | 450000 |
ANNEXON INC ANNX | 2022-08-16 20:45:05 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 20:15:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 19:45:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 19:15:05 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 18:45:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 18:15:05 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 17:45:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 17:15:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 16:45:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 16:15:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 15:45:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 15:15:03 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 14:45:03 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 14:15:04 UTC | 0.0008 | 2.3192 | 450000 |
ANNEXON INC ANNX | 2022-08-16 13:45:05 UTC | 0.0111 | 2.3089 | 450000 |
ANNEXON INC ANNX | 2022-08-16 13:15:04 UTC | 0.0111 | 2.3089 | 450000 |
ANNEXON INC ANNX | 2022-08-16 12:45:03 UTC | 0.0111 | 2.3089 | 450000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|